Editors' View January 2008
Overview of the human pharmacokinetics of recombinant activated factor VII
Pharmacokinetics and clinical efficacy of lorazepam in children with severe malaria and convulsions
The pharmacokinetics and effects of a long-acting preparation of superoxide dismutase (PC-SOD) in man
Population pharmacokinetic analysis of carboxyhaemoglobin concentrations in adult cigarette smokers
Effect of theophylline on the rate of moderate to severe exacerbations among patients with chronic obstructive pulmonary disease
Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine
Interindividual variability in the concentration–effect relationship of antilymphocyte globulins—a possible influence of FcγRIIIa genetic polymorphism
IMPDH activity in thiopurine-treated patients with inflammatory bowel disease – relation to TPMT activity and metabolite concentrations
No significant effect of SLCO1B1 polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone
Time-dependent inhibition of human drug metabolizing cytochromes P450 by tricyclic antidepressants
Interaction between midazolam and clarithromycin in the elderly
Exposure–response analysis reveals that clinically important toxicity difference can exist between bioequivalent carbamazepine tablets
Issues concerning the use of hormone replacement therapy and risk of fracture
Relationship between polypharmacy and underprescribing
The CYP2D6 polymorphism in relation to the metabolism of amitriptyline and nortriptyline in the Faroese population
A comparison of serum antivenom concentrations after intravenous and intramuscular administration of redback (widow) spider antivenom
Drug–drug interactions – a preventable patient safety issue?
Statins and phenytoin interact – a case history
Neutropenia induced in a patient by treatment with ritodrine